Meeting
2023 ASCO Gastrointestinal Cancers Symposium
SETD2 gene expression and the molecular landscape of colorectal cancer (CRC).
Authors
Francesca Battaglin
Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA;
Francesca Battaglin , Harris Krause , Andrew Elliot , Jim Abraham , Shivani Soni , Sandra Algaze , Priya Jayachandran , Hiroyuki Arai , Wu Zhang , Jae Ho Lo , Pooja Mittal , Benjamin Adam Weinberg , Emil Lou , Anthony Frank Shields , Richard M. Goldberg , Sanjay Goel , John Marshall , Gangning Liang , Wolfgang Michael Korn , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 184)
DOI
10.1200/JCO.2023.41.4_suppl.184
Abstract #
184
Poster Bd #
K6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Not all treated KRAS-mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome.
First Author: Bach Ardalan
Poster
2020 ASCO Virtual Scientific Program
The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies.
First Author: Matthew K Stein
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC.
First Author: Ibrahim Halil Sahin
Poster
2023 ASCO Annual Meeting
Characterizing the molecular landscape of early onset and average onset prostate cancer.
First Author: Ifeanyichukwu Ogobuiro